Hainan Biomedical Device920268.BJValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 19, 2026, Hainan Biomedical Device (920268.BJ) trades at a P/E of 19.50x, P/B of 3.69x, P/S of 5.93x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 50th percentile over the trailing 10Y window (vs. 50th percentile over 3Y); P/B sits at the 50th percentile over the trailing 10Y window (vs. 50th percentile over 3Y); P/S sits at the 50th percentile over the trailing 10Y window (vs. 50th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 25th percentile within its industry and the 24th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Cross-checking P/E against P/B, the two percentiles sit within 0.0 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Hainan Biomedical Device operates in the — sector. Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether Hainan Biomedical Device (920268.BJ) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 19.50 | ||||||
| P/B (MRQ) | 3.69 | ||||||
| P/S (TTM) | 5.93 | ||||||
| Dividend Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback + Div Yield | 0.00% | 0 | 0 | 0 | 0 | 0 | 0 |